Find your path to Alan
329 people in our graph share verified history with Alan — schools, employers, funds. One of them is your warm intro.
Sam BlackmanunlockedAlan: together at GlaxoSmithKline (2010)
×3Alan: together at GlaxoSmithKline
Alan: together at Nodthera
×2Alan: together at University of Hertfordshire
Executive Team at Nodthera
Intro paths
→
In turn, Alan can intro founders to Nodthera's investors below.
Experience
- NodTheraFounder & Chief Scientific Officercurrent2024 — presentCambridge, England, United Kingdom
- NodTheraChief Executive Officer2022 — 2024Cambridge, England, United Kingdom
- NodTheraChief Scientific Officer2018 — 2022Greater Cambridge Area
- NodTheraChief Scientific Officer/ Acting Chief Executive Officer2016 — 2018Greater Cambridge Area
- Babraham Institute Enterprise LtdChaircurrent2025 — presentBabraham, England, United Kingdom
- Babraham Institute Enterprise LtdNon Executive Director2017 — 2025Babraham, England, United Kingdom
- ESCP Business SchoolVisiting Lecturercurrent2017 — presentGreater London, England, United Kingdom
- Ducentis LimitedNon Executive Director2021 — 2022Oxford, England, United Kingdom
- XenoVidaCo-founder and Science Director2015 — 2022Canary Wharf, London
- The Babraham InstituteTrustee and Board Member2012 — 2017Greater Cambridge Area
- Bicycle TherapeuticsVice President, Therapeutics2015 — 2016Greater Cambridge Area
- Xenovium LimitedChief Executive Officer2014 — 2016Greater Cambridge Area
- Trident PharmaceuticalsCOO/EVP2013 — 2015Greater Cambridge Area
- Elemental Thinking LimitedManaging Director2010 — 2014Dunmow
- AutophagixCEO2012 — 2013Greater Cambridge Area
- CellzomeVice President, Therapeutics2010 — 2012Greater Cambridge Area
- GlaxoSmithKlineVice President2008 — 2010
- GlaxoSmithKlineDirector2006 — 2007
- Merck Sharp and DohmeSenior Director1985 — 2006
Skills & more
Drug Discovery64DMPK12Mentoring1ADME4Life Sciences11Bioanalysis3Pharmaceuticals1Coaching2Change ManagementDrug Metabolism12Lead OptimizationR&D10
+8 more
PharmacokineticsMass SpectrometryImmunologyNeuroscienceClinical DevelopmentLifesciencesMedicinal ChemistryPharmaceutical IndustryFrom Alan's professional profile.
Frequently asked questions
- Who is Alan P. Watt?
- Executive Team at Nodthera
- Where does Alan P. Watt work?
- Alan P. Watt is Executive Team at Nodthera.
- Where did Alan P. Watt go to school?
- Alan P. Watt studied at University of Southampton (BSc, Chemistry); Open Business School (MBA); University of Hertfordshire (PhD, Drug Metabolism).
Same school
Also attended University of Southampton157
Adrian RaduInvestor at Khosla VenturesLinda VõerasVenture Partner at Karma VenturesFrancesco MonacaInvestor at Giant Ventures Global LlpAlan MartinPartner at Marchmont VenturesLeah MartinHead of Marketing and Communications at Seraphim SpaceLewis JonesInvestment Principal at Seraphim Space
+ 151 more
Also attended University of Hertfordshire61
Roger FontAnalyst at Inveready Technology Investment GroupYogesh KamraHead of Lab Operations (UK site) at Illumina VenturesLucía SáenzInvestment & Community Intern at Kibo VenturesAlpesh AnandSalesforce Consultant & Administrator at EMV CapitalElaine HegartyChief of Staff at IQ CapitalMarco BrunsFinance & Operations Manager at Redstone
+ 55 more
Shared employers
Also worked at NodThera8
Mira ChaurushiyaManaging Director at Westlake Village BioPartnersKatie Bodner SpielbergPrincipal at 5AM VenturesAlex PasteurPartner at F-Prime Capital PartnersZhizhong YaoPartner at Sofinnova PartnersNIGEL CROCKETTExecutive Officer at BicycleGeoff McDonoughExecutive Team / Board at Nodthera
+ 2 more
Also worked at XenoVida1
Also worked at Bicycle Therapeutics7
Michael AnsteyPartner at Cambridge Innovation CapitalAnja KoenigGlobal Head of NVF at Novartis Venture FundAnja KönigGlobal Head at Novartis Venture FundCatherine StaceVP - Strategic Relationships at O2h VenturesAlex LeechPartner, Biovelocita Strategy at Sofinnova PartnersNIGEL CROCKETTExecutive Officer at Bicycle
+ 1 more
Also worked at GlaxoSmithKline275
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners
+ 269 more




































